Drug Profile


Alternative Names: FGIN 2023; FID 02023; RO 231412

Latest Information Update: 10 Oct 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fidia Farmaceutici; Roche
  • Class Antiepileptic drugs; Antipsychotics; Anxiolytics; Benzodiazepines; Imidazoles; Neuroprotectants; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Cocaine abuse; Epilepsy

Most Recent Events

  • 10 Oct 2003 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
  • 10 Oct 2003 Discontinued - Preclinical for Cocaine abuse in USA (unspecified route)
  • 10 Oct 2003 Discontinued for Epilepsy in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top